Overview

Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
Study Aims: - To compare the long-term efficacy and safety of imiquimod versus vehicle used as an adjunct to cryotherapy. - To assess and compare the recurrence rate and time to recurrence of the 2 different treatment groups. Hypothesis: The imiquimod arm will produce a more prolonged clearing of Actinic Keratoses (AK) compared to the vehicle arm.
Phase:
Phase 4
Details
Lead Sponsor:
Derm Research @ 888 Inc.
Collaborator:
3M
Treatments:
Imiquimod